You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 1.9% | 2.0% |
Div Cover | 1.3 | 2.6 |
Op Mrgn | 17.9% | 30.8% |
ROCE | 60.1% |
Latest | Forecast | |
---|---|---|
P/E | 40.0 | 0.0 |
PEG | 0.5 | 0.2 |
Price / Revenue | 5.2 | 3.7 |
Price / Book value | 6.1 |
Latest | Forecast | |
---|---|---|
Revenue | 3.3% | 2.7% |
PBT | 175.8% | n/a |
EPS | 81.1% | -38.7% |
DPS | 0.0% | -36.9% |
Year Ending | Revenue ($m) |
Pre-tax ($m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2019-12-31 | 24,384.00 | 1,548.00 | $1.03 | 97.9 | -2.5 | -39% | $2.80 | 2.8% |
2020-12-31 | 26,617.00 | 3,916.00 | $2.44 | 41.0 | 0.3 | 137% | $2.80 | 2.8% |
2021-12-31 | 37,417.00 | -265.00 | $0.08 | 1,467.0 | -15.2 | -97% | $2.87 | 2.4% |
2022-12-31 | 44,351.00 | 2,501.00 | $2.12 | 64.0 | 0.0 | 2,550% | $2.90 | 2.1% |
2023-12-31 | 45,811.00 | 6,899.00 | $3.84 | 35.2 | 0.4 | 81% | $2.90 | 2.1% |
AstraZeneca experimental lung cancer drug shows promising results Sharecast News | 28 May |
---|---|
Sector movers: Stocks slip amid light profit-taking Sharecast News | 21 May |
London close: Stocks fall ahead of key inflation reading Sharecast News | 21 May |
Dato-DXd improved OS in nonsquamous lung cancer | 28-May-24 07:01 |
---|---|
AstraZeneca to deliver $80bn revenue by 2030 | 21-May-24 07:01 |
AstraZeneca to manufacture ADCs in Singapore | 20-May-24 07:01 |
SUPERNOVA Trial Met COVID-19 prevention endpoint | 16-May-24 07:01 |
Director/PDMR Shareholding | 15-May-24 15:00 |